209 related articles for article (PubMed ID: 19770698)
1. Early mortality and cause of deaths in patients using HAART in Brazil and the United States.
Grinsztejn B; Veloso VG; Friedman RK; Moreira RI; Luz PM; Campos DP; Pilotto JH; Cardoso SW; Keruly JC; Moore RD
AIDS; 2009 Oct; 23(16):2107-14. PubMed ID: 19770698
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil.
Grinsztejn B; Veloso VG; Pilotto JH; Campos DP; Keruly JC; Moore RD
J Acquir Immune Defic Syndr; 2007 Aug; 45(5):515-20. PubMed ID: 17558332
[TBL] [Abstract][Full Text] [Related]
3. Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study.
Coelho L; Grinsztejn B; Castilho JL; De Boni R; Quintana MS; Campos DP; Ribeiro SR; Pacheco AG; Veloso VG; Luz PM
Lancet HIV; 2016 Oct; 3(10):e490-8. PubMed ID: 27658875
[TBL] [Abstract][Full Text] [Related]
4. Immune status at presentation for HIV clinical care in Rio de Janeiro and Baltimore.
Moreira RI; Luz PM; Struchiner CJ; Morgado M; Veloso VG; Keruly JC; Grinsztejn B; Moore RD
J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 3(Suppl 3):S171-8. PubMed ID: 21857314
[TBL] [Abstract][Full Text] [Related]
5. Early mortality in a cohort of people living with HIV in Rio de Janeiro, Brazil, 2004-2015: a persisting problem.
Leite PHAC; Coelho LE; Cardoso SW; Moreira RI; Veloso VG; Grinsztejn B; Luz PM
BMC Infect Dis; 2022 May; 22(1):475. PubMed ID: 35581552
[TBL] [Abstract][Full Text] [Related]
6. Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil.
Pacheco AG; Tuboi SH; May SB; Moreira LF; Ramadas L; Nunes EP; Merçon M; Faulhaber JC; Harrison LH; Schechter M
J Acquir Immune Defic Syndr; 2009 Aug; 51(5):624-30. PubMed ID: 19430304
[TBL] [Abstract][Full Text] [Related]
7. Gender and survival after AIDS in Rio de Janeiro, Brazil.
Santoro-Lopes G; Harrison LH; Moulton LH; Lima LA; de Pinho AM; Hofer C; Schechter M
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):403-7. PubMed ID: 9833750
[TBL] [Abstract][Full Text] [Related]
8. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.
Palella FJ; Baker RK; Moorman AC; Chmiel JS; Wood KC; Brooks JT; Holmberg SD;
J Acquir Immune Defic Syndr; 2006 Sep; 43(1):27-34. PubMed ID: 16878047
[TBL] [Abstract][Full Text] [Related]
9. Prevalent tuberculosis at HIV diagnosis in Rio de Janeiro, Brazil: the TB/HIV in Rio (THRio) Cohort.
Saraceni V; Cohn S; Cavalcante SC; Pacheco AG; Moulton LH; Chaisson RE; Durovni B; Golub JE
J Acquir Immune Defic Syndr; 2014 Sep; 67(1):98-101. PubMed ID: 24933097
[TBL] [Abstract][Full Text] [Related]
10. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.
Brady MT; Oleske JM; Williams PL; Elgie C; Mofenson LM; Dankner WM; Van Dyke RB;
J Acquir Immune Defic Syndr; 2010 Jan; 53(1):86-94. PubMed ID: 20035164
[TBL] [Abstract][Full Text] [Related]
11. Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil.
Saraceni V; Durovni B; Cavalcante SC; Cohn S; Pacheco AG; Moulton LH; Chaisson RE; Golub JE
Braz J Infect Dis; 2014; 18(5):491-5. PubMed ID: 24780362
[TBL] [Abstract][Full Text] [Related]
12. Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART.
Schmaltz CA; Santoro-Lopes G; Lourenço MC; Morgado MG; Velasque Lde S; Rolla VC
PLoS One; 2012; 7(9):e45704. PubMed ID: 23049842
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
Sterling TR; Chaisson RE; Moore RD
AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
[TBL] [Abstract][Full Text] [Related]
14. Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life.
Torres TS; Cardoso SW; Velasque Lde S; Marins LM; Oliveira MS; Veloso VG; Grinsztejn B
Braz J Infect Dis; 2013; 17(3):324-31. PubMed ID: 23602466
[TBL] [Abstract][Full Text] [Related]
15. Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART.
Taiwo BO; Li X; Palella F; Jacobson LP; Margolick JB; Detels R; Rinaldo CR; Phair JP
HIV Med; 2009 Nov; 10(10):657-60. PubMed ID: 19601997
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression.
Jacobson LP; Li R; Phair J; Margolick JB; Rinaldo CR; Detels R; Muñoz A
Am J Epidemiol; 2002 Apr; 155(8):760-70. PubMed ID: 11943695
[TBL] [Abstract][Full Text] [Related]
17. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.
Yang CH; Huang YF; Hsiao CF; Yeh YL; Liou HR; Hung CC; Yang SY
HIV Med; 2008 Aug; 9(7):535-43. PubMed ID: 18554309
[TBL] [Abstract][Full Text] [Related]
18. Mortality in patients with HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil - associated factors and causes of death.
da Silva Escada RO; Velasque L; Ribeiro SR; Cardoso SW; Marins LMS; Grinsztejn E; da Silva Lourenço MC; Grinsztejn B; Veloso VG
BMC Infect Dis; 2017 May; 17(1):373. PubMed ID: 28558689
[TBL] [Abstract][Full Text] [Related]
19. All-cause mortality in hospitalized HIV-infected patients at an acute tertiary care hospital with a comprehensive outpatient HIV care program in New York City in the era of highly active antiretroviral therapy (HAART).
Kim JH; Psevdos G; Gonzalez E; Singh S; Kilayko MC; Sharp V
Infection; 2013 Apr; 41(2):545-51. PubMed ID: 23264096
[TBL] [Abstract][Full Text] [Related]
20. Absence of effect of menopause status at initiation of first-line antiretroviral therapy on immunologic or virologic responses: a cohort study from Rio de Janeiro, Brazil.
Calvet GA; Velasque L; Luz PM; Cardoso SW; Derrico M; Moreira RI; de Andrade AC; Cytryn A; Pires E; Veloso VG; Grinsztejn B; Friedman RK
PLoS One; 2014; 9(2):e89299. PubMed ID: 24586673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]